Vender on Psoriasis: Recent Episodes
Chronicle Companies
Ronald B. Vender, MD, FRCPC comments on recent findings and developments in dermatologic studies, and answers listeners' questions.
Canadian dermatologist Dr. Ronald B. Vender discusses topical methotrexate, systemic medications in pediatric patients, and depression.
Canadian dermatologist Dr. Ronald B. Vender discusses whether or not vitamin D has any impact on psoriasis severity, sex differences in psoriatic inflammation itch, and risk of psychiatric disorders associated with acitretin.
Canadian dermatologist Dr. Ronald B. Vender discusses psoriatic skin lesions, methotrexate and nonmelanoma skin cancer, and face-to-face time between patients and physicians.
Canadian dermatologist Dr. Ronald B. Vender discusses comorbid obesity, the effect of smoking on psoriasis, and apremilast in real world studies.
Canadian dermatologist Dr. Ronald B. Vender discusses mental health comorbidities of psoriasis, restless legs syndrome, and shared decision-making with dermatologists.
Canadian dermatologist Dr. Ronald B. Vender discusses PASI thresholds, migraines, and the importance of topical treatment application feel to a patient.
Canadian dermatologist Dr. Ronald B. Vender talks about paradoxical eczema in psoriasis patients on biologics, real-world blood screening, and patient satisfaction for brodalumab.
Canadian dermatologist Dr. Ronald B. Vender talks about acitretin-methotrexate therapy in pediatric patients, psoriasis flares from systemic steroids, and adalimumab with methotrexate versus adalimumab mono therapy.
Canadian dermatologist Dr. Ronald B. Vender talks about treating psoriasis with teledermatology during the pandemic, air pollution triggering psoriasis flares, and ixekizumab response in pediatric plaque psoriasis patients.
Canadian dermatologist Dr. Ronald B. Vender talks about a link between psoriasis and non-alcoholic fatty liver disease, vaccine hesitancy in psoriasis patients, and bimekizumab safety profiles.
Canadian dermatologist Dr. Ronald B. Vender talks about psoriasis treatment efficacy in body regions, use of analgesics, and lifestyle factors and genetic risks of incident psoriasis.
Canadian dermatologist Dr. Ronald B. Vender talks about self-help for psoriasis patients, generalized pustular psoriasis and the link between early response and long-term response in psoriasis treatment.
Canadian dermatologist Dr. Ronald B. Vender talks about biologics use, biosimilars and the potential risk of incident venous thromboembolism and peripheral vascular disease in psoriasis.
Canadian dermatologist Dr. Ronald B. Vender talks about breastfeeding with psoriasis, the potential link between childhood psoriasis and tobacco exposure, and treating plaque psoriasis with tapinarof cream.
Canadian dermatologist Dr. Vender talks about treating patients with ustekinumab withdrawal, combination therapy for plaque psoriasis and the potential link between chronic kidney disease and psoriasis.
Canadian dermatologist Dr. Vender talks about the effect of alcohol on treatment response, biologic fatigue and treatment changes in biologics.
Canadian dermatologist Dr. Vender talks about biologic treatment safety during Covid-19, the effect of intermittent fasting on psoriasis and five-year data on using tildrakizumab to treat psoriasis patients.
Canadian dermatologist Dr. Vender talks about treatment efficacy using PASI scores, using botox for plaque psoriasis and the independent mortality risk associated with psoriasis.